Skip to content
The GLP-1 Verdict
Menu

Head-to-head verdict

CoreAge Rx vs Go Vida Plena

Two GLP-1 providers, compared side by side on The Verdict Score — our published six-factor rubric. Same yardstick, and no score is adjusted for payment.

Published by The GLP-1 Verdict

Pricing sources checked: CoreAge Rx: August 2026 · Go Vida Plena: Check date not recorded

WinnerGrade A · #1

CoreAge Rx

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

Visit CoreAge Rx
vs
Grade C · #140

Go Vida Plena

Go Vida Plena is a Spanish-first, Latino-focused medical weight-loss program offering GLP-1 therapy from $199/month, based in Utah.

Visit Go Vida Plena

The verdict

Winner: CoreAge Rx

CoreAge Rx takes it with a higher Verdict Score — 94/100 to 71/100 (grade A vs C). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Go Vida Plena still earns its place — shoppers who want spanish-speaking patients wanting a bilingual, Latino-food-friendly GLP-1 program from $199/mo.

The score compares published program terms and features; it does not measure clinical outcomes or predict which treatment will suit you.

Factor by factor

Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.

92Real-world results80
97Price honesty64
96Prescriber access53
88Formulary choice88
95Cancellation fairness56
93Member support88

Price, coverage & features

MetricCoreAge RxGo Vida Plena
Verdict Score94/10071/100
GradeAC
Semaglutide$99/moFrom $199/mo (starting dose, compounded)
Tirzepatide$149/moFrom $269/mo (starting dose, compounded)
CoverageAll 50 statesNot disclosed
Brand-name accessCompounded onlyCompounded only
Oral / sublingualNoYes

CoreAge Rx

What we like

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation

The caveats

  • Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Go Vida Plena

What we like

  • Spanish-first, fully bilingual GLP-1 program tailored to Latino food and lifestyle - a genuinely underserved niche
  • Compounded semaglutide, tirzepatide, and oral semaglutide from $199/mo, with installment pay (Klarna, Afterpay, Affirm)
  • Free initial consultation; medications shipped discreetly to your door after a medical evaluation
  • Includes 24/7 support, 4 virtual visits a year, and ongoing nutrition coaching
  • Physician-supervised program (Utah medical backing) with continuous follow-up

The caveats

  • Utah-based, and the full list of states served is not published
  • Only a '$199/mo starting' price is shown upfront; tirzepatide and oral-semaglutide pricing isn't published
  • The compounding pharmacy is not named (a 'provider pharmacies' page exists but lists no name)
  • Compounded GLP-1 medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • No LegitScript certification displayed

Our pick — visit

Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.

Visit CoreAge Rx Read the full CoreAge Rx review →

Also worth a look

Shoppers who want spanish-speaking patients wanting a bilingual, Latino-food-friendly GLP-1 program from $199/mo.

Visit Go Vida Plena Read the full Go Vida Plena review →

Keep comparing

Neither of these has to be the answer: the rivals we rank against CoreAge Rx cover the 7 programs closest to it, and the same shortlist for Go Vida Plena does the reverse.

Or browse the full comparison hub, every head-to-head A to Z and the complete rankings.

Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.